Evaluation and management of hemorrhage during TURP

Answer generated by Itaca · 5 sources · February 02, 2025

Original question

Evaluation and management of haemorrhage during TURP.... source your answer only from pubmed research articles and article reviewof literature

Summary

Haemorrhage during Transurethral Resection of the Prostate (TURP) is a significant concern due to its potential for morbidity and mortality. Management strategies include preoperative cessation of anticoagulant and antiplatelet medications, the use of pharmacologic agents like 5α-reductase inhibitors and tranexamic acid, and technical considerations such as bipolar and laser technologies to reduce bleeding risks[1][2][3]. Effective management requires a comprehensive approach to prevent and treat hemorrhage, considering both the surgical technique and pharmacological interventions.

Prevention Strategies

Preventing hemorrhage during TURP involves several key strategies:

  • Preoperative Medication Management: Stopping anticoagulant and antiplatelet medications before surgery is crucial, although this requires careful assessment of thrombotic risks[1].
  • Pharmacologic Interventions:
    • 5α-reductase Inhibitors: Finasteride and dutasteride have been shown to reduce perioperative bleeding by decreasing microvessel density in the prostate[3].
    • Tranexamic Acid: This antifibrinolytic agent has demonstrated efficacy in reducing blood loss during bipolar TURP, though more studies are needed to confirm its benefits across different surgical techniques[2].
  • Surgical Techniques:
    • Bipolar and Laser Technologies: These methods offer improved hemostasis compared to traditional monopolar techniques, reducing the risk of bleeding[1][4].

Management of Haemorrhage

In cases where hemorrhage occurs, management involves both immediate intervention and potential further procedures:

  • Immediate Hemostasis: Endoscopic fulguration is often used initially to control bleeding[5].
  • Advanced Interventions: In severe cases refractory to conventional methods, selective arterial embolization may be necessary to control hemorrhage[5].
  • Monitoring and Supportive Care: Close monitoring of vital signs and fluid management is essential to prevent complications such as TUR syndrome[4].

Clinical Decision-Making

When deciding on the best approach for managing hemorrhage during TURP, clinicians must consider the patient's overall health status, the presence of comorbidities, and the specific surgical technique being used. This includes weighing the benefits of pharmacologic interventions against potential risks and ensuring that appropriate surgical equipment is available.

Patient Safety and Risks

Patient safety is paramount, with considerations including:

  • Thromboembolic Risks: While tranexamic acid is generally safe, there is a theoretical risk of thromboembolic events, particularly in older patients[2].
  • TUR Syndrome: Although less common with bipolar techniques, TUR syndrome remains a risk due to fluid absorption during surgery[4].

Sources

  1. https://pubmed.ncbi.nlm.nih.gov/21844906/
  2. https://www.scielo.br/j/eins/a/kkLGrpkcjRTk4tyQWpPNDnp/
  3. https://pubmed.ncbi.nlm.nih.gov/28650680/
  4. https://www.ncbi.nlm.nih.gov/books/NBK560884/
  5. https://pubmed.ncbi.nlm.nih.gov/19956198/

AI-generated answer based on the cited sources. Check the sources before applying it.

Have a question about your own case? Itaca answers with sources in seconds.

Ask a question

More questions about Transurethral Resection of Prostate